Knott David M Jr Bridge Bio Pharma, Inc. Transaction History

Knott David M Jr

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$23.0 - $31.04 $115,000 - $155,200	5,000 Added 31.25%	21,000 $532,000
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $109,400 - $161,800	4,000 Added 33.33%	16,000 $495,000
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $72,060 - $131,670	3,000 Added 33.33%	12,000 $484,000
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $152,010 - $315,090	9,000 New	9,000 $237,000
Q3 2022 Nov 10, 2022	SELL	$7.94 - $12.36 $556,673 - $866,559	-70,110 Reduced 32.88%	143,096 $1.42 Million
Q2 2022 Aug 11, 2022	BUY	$5.21 - $12.14 $64,150 - $149,479	12,313 Added 6.13%	213,206 $1.94 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $1.47 Million - $3.45 Million	200,893 New	200,893 $2.04 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.